Title: Surgical Treatment Modalities, Mortality and Morbidity in Pancreatic Cancer Patients in Misurata Cancer Center

Authors: Ramadan Elamyal, Mussa Al Ragig, Naji Zubia

 DOI:  https://dx.doi.org/10.18535/jmscr/v6i1.79

Abstract

Introduction: the pancreas is a glandular organ of dual composition with both exocrine and endocrine components. Tumors of exocrine pancreases are rare with more than 95% being malignant.

Methods & Materials: this is a retrospective clinico-histopathological study of 89 cases registered in our center from July 2005 to Jan 2015. The details of patients were retrieved from patients’ files.  Information retrieved included socio-demographic data, clinical presentation, anatomical site, gross appearance, tumor stage, histopathological type and grade, surgical treatment modality and presence of metastasis.

Results: during the study period, a total of 89 malignancies were registered. Of these, 48 (53.9%) were histopathologically confirmed pancreatic cancer. The diagnosis in the remaining 41 patients was based on clinical and radiological basis. Male to female ratio of 1.6:1. The age ranged from 35 to 90 years with a median age of 63 years. Fifty seven patients (64%) presented with abdominal pain, 41 patients (46%) were jaundiced. The head was the most frequent site for pancreatic tumor in 48 (54%) cases followed by tail, body. Adenocarcinoma was the most common histopathological tumor in 43(90%) patients. Thirty (33.7%) patients were presented in locally advanced stages and 54(60.6 %) patients had metastasis.

Conclusion: Our study was limited by being a retrospective, a relatively small number of patients and representing the experience of a single cancer center so, larger scale prospective studies are recommended to study the clinicodemografic character of this disease in the country.

Keywords: Pancreatic Cancer, clinical, demographic, retrospective.

References

  1. Abraham A, Al-Refaie WB, Parsons HM, Dudeja V, Vickers SM, Habermann EB. Disparities in Pancreas Cancer Care. Ann Surg Oncol [Internet]. 2013 Abril [acesso em 2013 Maio 15];10434-012. Disponível em: http://www.ncbi.nlm.nih.gov/pubmed/23579872.
  2. Amico EC, Alves JR, João SA, Guimarães PL, Barreto EJ, Barreto LS, Costa PR, Medeiros JA. Complications after pancreatectomies: prospective study after ISGFP and ISGPS new classifications. Arq Bras Cir Dig. 2013 Jul-Sep;26(3):213-8.
  3. Beger HG, Matsuno S, Cameron JL. Diseases of the Pancreas - Current Surgical Therapy. Berlin: Springer, 2008.
  4. Chari ST, Leibson CL, Rabe KG, Timmons LJ, Ransom J, de Andrade M, Petersen GM. Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology. 2008;134(1):95-101
  5. Kamphues C, Bova R, Schricke D, Hippler-Benscheidt M, Klauschen F, Stenzinger A, Seehofer D, Glanemann M, Neuhaus P, Bahra M. Postoperative Complications Deteriorate Long-Term Outcome in Pancreatic Cancer Patients. Ann Surg Oncol [Internet] . 2011 Abril [acesso em 2011 Ago 30]; 2041-4. Disponível em: http://www.ncbi.nlm.nih.gov/pubmed/21879265
  6. Lefebvre AC, Maurel J, Boutreux S, Bouvier V, Reimund JM, Launoy G, Arsene D. Pancreatic cancer: incidence, treatment and survival trends--1175 cases in Calvados (France) from 1978 to 2002. Gastroenterol Clin Biol. 2009;33(10-11):1045-51.
  7. Luke C, Price T, Karapetis C, Singhal N, Roder D. Pancreatic cancer epidemiology and survival in an Australian population. Asian Pac J Cancer Prev. 2009;10(3):369-74.
  8. Lowenfels AB, Maisonneuve P. Epidemiology of pancreatic cancer. In Beger HG, Matsuno S, Cameron JL. Diseases of the pancreas: current surgical therapy. Germany: ed. Springer-Verlag Berlin Heidelberg; 2008:489-94.
  9. Lermite E, Pessaux P, Teyssedou C, Etienne S, Brehant O, Arnaud JP. Effect of preoperative endoscopic biliary drainage on infectious morbidity after pancreatoduodenectomy: a case- control study. Am J Surg. 2008;195(4):442-6.
  10. Hartwig W, Hackert T, Hinz U, Gluth A, Bergmann F, Strobel O, Büchler MW, Werner J. Pancreatic Cancer Surgery in the New Millennium Better Prediction of Outcome. Ann Surg. 2011;254(2):311-9.
  11. Büchler MW, Wagner M, Schmied BM, Uhl W, Friess H, Z'graggen K. Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy. Arch Surg. 2003;138:1310–4; disucssion 1315. .
  12. Winter JM, Cameron JL, Campbell KA, Arnold MA, Chang DC, Coleman J, et al. 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience. J Gastrointest Surg. 2006;10:1199–210; discussion 1210-1.
  13. Tanaka M, Sarr MG. Role of the duodenum in the control of canine gastrointestinal motility. Gastroenterology. 1988;94:622–9.
  14. Matheus AS, Montagnini AL, Jukemura J, Jurendini R, Penteado S, Abdo EE, Cunha JEM. Risk factors for pancreatic fistula. Does it have a clinical application for early identification of patients with high risk to develop pancreatic fistula after pancreaticoduodenectomy? . Gastroenterol 2006;130(4) supl2.

Corresponding Author

Ramadan Elamyal

MD Consultant Surgeon, Misurata Cancer Center, Misurata, Libya

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.